Assessment confirms safety of Vitamin D2 Mushroom Powder in novel food applications, indicating suitability for consumption.
The Food Standards Agency (FSA) and Food Standards Scotland (FSS) have undertaken an assessment of application RP1158 for the safety of Vitamin D2 Mushroom Powder (Agaricus bisporus) as a novel food, from MBio. A novel food application has been received by Great Britain (GB) where the European Food Safety Agency (EFSA), prior to the end of the transition period, evaluated an application for the product. FSA/FSS has reviewed the EFSA opinion for this novel food (EFSA NDA Panel, 2021b) and confirmed that this is adequate for GB risk analysis. Therefore, the opinion was used to form the basis of the GB opinion. The FSA/FSS risk assessors concluded that Vitamin D2 Mushroom Powder, as described in the EFSA opinion (EFSA NDA Panel, 2021b), is safe based on the composition, the anticipated intake levels, and at the proposed conditions of use.
No takes yet. Share an insight, caveat, or question.
Agency et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: